HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ticarcillin disodium in anaerobic infections.

Abstract
Twenty-five patients were treated with ticarcillin disodium, 18 of whom had anaerobic infections that included pleuropulmonary infections (seven), mandibular osteomyelitis (four), perirectal abscess (two), sepsis, primary site unknown (one), liver abscess (one), pelvic abscess (one), decubitus ulcer (one), and synergistic gangrene (one). Seven had no anaerobic infections. Three had anaerobic septicemia. Culture results included anaerobes: peptococci (ten), peptostreptococci (ten), Bacteroides fragilis (six), Bacteroides not fragilis (ten), eubacteria (three), fusobacteria (two), Clostridium (one), Veillonella (one), and acidaminococcus (one); aerobes: Proteus (three), Klebsiella (two), Escherichia coli (two), and streptococci (two). Six patients with mixed aerobic infections initially received gentamicin sulfate in addition. The serum levels were 110 +/- 20 microgram/ml one hour after intravenous infusion of 5 g of ticarcillin disodium. All anaerobic isolates were susceptible at less than or equal to 100 microgram/ml and 85% by less than or equal to 25 microgram/ml of ticarcillin. Sixteen patients responded well to ticarcillin and two failed to respond. Our study suggests that ticarcillin is useful in the treatment of anaerobic infections.
AuthorsD Webb, H Thadepalli, I Roy, V T Bach
JournalArchives of internal medicine (Arch Intern Med) Vol. 138 Issue 11 Pg. 1618-20 (Nov 1978) ISSN: 0003-9926 [Print] United States
PMID718311 (Publication Type: Journal Article)
Chemical References
  • Penicillins
  • Ticarcillin
Topics
  • Anaerobiosis
  • Bacterial Infections (drug therapy)
  • Bacteroides (isolation & purification)
  • Bacteroides Infections (drug therapy)
  • Bacteroides fragilis (drug effects)
  • Humans
  • Mandibular Diseases (drug therapy, microbiology)
  • Osteomyelitis (drug therapy, microbiology)
  • Penicillins (therapeutic use)
  • Peptococcus (drug effects, isolation & purification)
  • Peptostreptococcus (drug effects, isolation & purification)
  • Ticarcillin (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: